共 188 条
[1]
Crossno JT(2007)Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling Am J Physiol Lung Cell Mol Physiol 292 L885-97
[2]
Garat CV(2010)Role of epidermal growth factor inhibition in experimental pulmonary hypertension Am J Respir Crit Care Med 181 158-67
[3]
Reusch JE(2011)Vascular remodeling in pulmonary arterial hypertension: multiple cancer-like pathways and possible treatment modalities Int J Cardiol 147 4-12
[4]
Morris KG(2002)Pulmonary hypertension in collagen vascular disease Eur Respir J 19 571-6
[5]
Dempsey EC(2003)Pulmonary hypertension in the collagen vascular diseases Semin Respir Crit Care Med 24 287-96
[6]
McMurtry IF(2008)CPU86017 and its isomers improve hypoxic pulmonary hypertension by attenuating increased ETA receptor expression and extracellular matrix accumulation Naunyn Schmiedebergs Arch Pharmacol 378 541-52
[7]
Dahal BK(2006)New insights in the treatment strategy for pulmonary arterial hypertension Cardiovasc Drugs Ther 20 377-86
[8]
Cornitescu T(2010)Contribution of oxidative stress to pulmonary arterial hypertension World J Cardiol 2 316-24
[9]
Tretyn A(2012)Reactive oxygen and nitrogen species in pulmonary hypertension Free Radic Biol Med 52 1970-86
[10]
Pullamsetti SS(2006)Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms Circ Res 99 675-91